LINDSAY ARBOGAST: Open Payments
NPI 1669974267 · PHILIPPI, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 44 payments from 10 companies in 2025. Trend: 2023 $675 · 2024 $779 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $503 |
| AstraZeneca Pharmaceuticals LP | 5 | $247 |
| Exact Sciences Corporation | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Lilly USA, LLC | 1 | $24 |
| Organogenesis Inc. | 1 | $22 |
| UCB, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, AIRSUPRA, UBRELVY, QULIPTA, The Cologuard Plus Collection Kit, SPRAVATO, CAPLYTA, FARXIGA.
Industry payments across WV — which companies pay providers there.
